These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 8402636)
1. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells. Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636 [TBL] [Abstract][Full Text] [Related]
2. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin. Gong J; Li X; Darzynkiewicz Z J Cell Physiol; 1993 Nov; 157(2):263-70. PubMed ID: 8227159 [TBL] [Abstract][Full Text] [Related]
3. Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue. Hendricks CB; Rowinsky EK; Grochow LB; Donehower RC; Kaufmann SH Cancer Res; 1992 Apr; 52(8):2268-78. PubMed ID: 1348448 [TBL] [Abstract][Full Text] [Related]
4. The modulation of the DNA-damaging effect of polycyclic aromatic agents by xanthines. Part I. Reduction of cytostatic effects of quinacrine mustard by caffeine. Kapuscinski J; Ardelt B; Piosik J; Zdunek M; Darzynkiewicz Z Biochem Pharmacol; 2002 Feb; 63(4):625-34. PubMed ID: 11992630 [TBL] [Abstract][Full Text] [Related]
5. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228 [TBL] [Abstract][Full Text] [Related]
6. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan. Danks MK; Garrett KE; Marion RC; Whipple DO Cancer Res; 1996 Apr; 56(7):1664-73. PubMed ID: 8603418 [TBL] [Abstract][Full Text] [Related]
7. Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Traganos F; Kapuscinski J; Darzynkiewicz Z Cancer Res; 1991 Jul; 51(14):3682-9. PubMed ID: 2065324 [TBL] [Abstract][Full Text] [Related]
8. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Mattern MR; Hofmann GA; McCabe FL; Johnson RK Cancer Res; 1991 Nov; 51(21):5813-6. PubMed ID: 1657371 [TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Gabr A; Kuin A; Aalders M; El-Gawly H; Smets LA Cancer Res; 1997 Nov; 57(21):4811-6. PubMed ID: 9354443 [TBL] [Abstract][Full Text] [Related]
10. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631 [TBL] [Abstract][Full Text] [Related]
11. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. Del Bino G; Darzynkiewicz Z Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159 [TBL] [Abstract][Full Text] [Related]
12. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan. Subramanian D; Muller MT Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290 [TBL] [Abstract][Full Text] [Related]
13. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. Del Bino G; Skierski JS; Darzynkiewicz Z Cancer Res; 1990 Sep; 50(18):5746-50. PubMed ID: 2168279 [TBL] [Abstract][Full Text] [Related]
14. Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure. Danks MK; Pawlik CA; Whipple DO; Wolverton JS Clin Cancer Res; 1997 Oct; 3(10):1731-8. PubMed ID: 9815557 [TBL] [Abstract][Full Text] [Related]
15. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166 [TBL] [Abstract][Full Text] [Related]
16. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. Hotz MA; Del Bino G; Lassota P; Traganos F; Darzynkiewicz Z Cancer Res; 1992 Mar; 52(6):1530-5. PubMed ID: 1540962 [TBL] [Abstract][Full Text] [Related]
17. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Kaufmann SH Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800 [TBL] [Abstract][Full Text] [Related]
18. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Del Bino G; Li X; Traganos F; Darzynkiewicz Z Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535 [TBL] [Abstract][Full Text] [Related]
19. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line. Zhang J; Cheng C; He CL; Zhou YJ; Cao Y Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767 [TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens. Cheng MF; Chatterjee S; Berger NA Oncol Res; 1994; 6(6):269-79. PubMed ID: 7865902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]